Interaction of matrix metalloproteinases with serine protease inhibitors. New potential roles for matrix metalloproteinase inhibitors.
Mallya
S K
SK
Department of Biochemistry and Cell Biology, State University of New York at Stony Brook 11794.
Hall
J E
JE
Lee
H M
HM
Roemer
E J
EJ
Simon
S R
SR
Golub
L M
LM
D000818:Animals; D002478:Cells, Cultured; D017364:Collagenases / Q000378:metabolism*; D004318:Doxycycline / Q000494:pharmacology; D005109:Extracellular Matrix / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D020784:Matrix Metalloproteinase 8; D061965:Matrix Metalloproteinase Inhibitors; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D009130:Muscle, Smooth; D009504:Neutrophils / Q000502:physiology*; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D000515:alpha 1-Antitrypsin / Q000494:pharmacology*
D061965:Matrix Metalloproteinase Inhibitors; D000515:alpha 1-Antitrypsin; D017364:Collagenases; D008666:Metalloendopeptidases; D020784:Matrix Metalloproteinase 8; D004318:Doxycycline; D013755:Tetradecanoylphorbol Acetate